Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

73.05
Delayed Data
As of 4:01pm ET
 -1.07 / -1.44%
Today’s Change
69.90
Today|||52-Week Range
106.84
-15.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line9.6B9.3B10.6B7.0B
 
 
 
 
 
Depreciation4.6B4.7B4.3B5.2B
 
 
 
 
 
Total Other Cash Flow118.0M-161.9M-559.4M506.1M
 
 
 
 
 
Funds From Operations14.3B13.9B14.4B12.7B
 
 
 
 
 
Funds From/For Other Operating Expenses140.0M738.5M617.8M861.5M
 
 
 
 
 
Net Cash Flow - Operating Activities14.2B13.1B13.7B11.9B
 
 
 
 
 
 
InvestingIncrease In Investments-1.8B-442.7M-403.3M-857.5M
 
 
 
 
 
Decrease In Investments737.2M563.6M3.8B427.2M
 
 
 
 
 
Capital Expenditures-2.7B-3.1B-2.6B-2.4B
 
 
 
 
 
Fixed Asset Disposal92.0M60.0M59.3M236.6M
 
 
 
 
 
Net Assets From Acquisitions -1.7B-42.0M-327.2M-16.5B
 
 
 
 
 
Other Investing - Uses-57.0M-39.0M-59.3M-81.9M
 
 
 
 
 
Other Investing - Sources181.0M170.9M1.1B9.5B
 
 
 
 
 
Net Cash Flow Investing-5.7B-3.3B870.8M-10.8B
 
 
 
 
 
 
FinancingShort Term Borrowings-1.7B595.6M-105.8M450.2M
 
 
 
 
 
Long Term Borrowings2.0B92.9M6.0B4.6B
 
 
 
 
 
Long Term Debt Reduction-704.2M-2.0B-2.6B-3.1B
 
 
 
 
 
Net Proceeds Stock Sale414.1M1.7B0.000.00
 
 
 
Common Preferred Redeemed-505.1M-2.9B-6.8B-6.1B
 
 
 
 
 
Common Dividends-6.0B-6.1B-6.7B-6.6B
 
 
 
 
 
Cash Dividends Paid - Total-6.0B-6.1B-6.7B-6.6B
 
 
 
 
 
Other Sources - Financing0.004.0M2.4B1.6B
 
 
 
 
Other Uses - Financing92.0M102.9M138.4M4.0M
 
 
 
 
 
Net Cash Flow - Financing-6.7B-8.8B-8.1B-9.2B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.0M81.9M-291.6M-285.5M
 
 
 
 
 
 
Net Change In Cash1.8B1.1B6.6B-8.0B